Global Innovative Platforms Inc. (GIPL)
Global Innovative Platforms Inc. engages in the business of testing breath to detect and assist in the treatment of disease. The company develops Heartworm breath test, which includes breath collection device, to collect shallow breath samples. It also operates VOCAM Plus and FROG platform for gas chromatography, as well as operates A.I. software to provide breath and air analysis. The company was formerly known as Canning Str Corp. and changed its name to Global Innovative Platforms Inc. in September 2021. Global Innovative Platforms Inc. was incorporated in 2020 and is based in Sanford, Florida.
Sector: Surgical & Medical Instruments & Apparatus
Industry: Information Technology Services
Global Innovative Platforms Inc.
OTC:GIPLTechnology · Information Technology Services
Mkt Cap$24.88M
Float26.97M
O/S49.75M
Inst Own-
Dilution
MCap$24.88M
Float26.97M
O/S49.75M
Dilution